- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 211/76 - Oxygen atoms attached in position 2 or 6
Patent holdings for IPC class C07D 211/76
Total number of patents in this class: 277
10-year publication summary
|
24
|
25
|
15
|
21
|
21
|
21
|
17
|
15
|
18
|
16
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Amgen Inc. | 4440 |
24 |
| California Institute of Technology | 4036 |
8 |
| Bristol-myers Squibb Company | 4757 |
7 |
| Codexis, Inc. | 815 |
7 |
| The Scripps Research Institute | 1344 |
7 |
| Arvinas Operations, Inc. | 263 |
7 |
| Takeda Pharmaceutical Company Limited | 2700 |
6 |
| InterMune, Inc. | 47 |
5 |
| Daikin Industries, Ltd. | 10502 |
4 |
| Institut Univ. de Ciencia i Tecnologia, S.A. | 22 |
4 |
| Queen's University at Kingston | 544 |
4 |
| Tetraphase Pharmaceuticals, Inc. | 52 |
4 |
| BASF SE | 21306 |
3 |
| Pfizer Inc. | 3409 |
3 |
| Merck Patent GmbH | 5735 |
3 |
| Abbott Laboratories | 2241 |
3 |
| Cedars-Sinai Medical Center | 1208 |
3 |
| ChemoCentryx, Inc. | 361 |
3 |
| Cocrystal Pharma, Inc. | 44 |
3 |
| Dart NeuroScience, LLC | 50 |
3 |
| Other owners | 166 |